These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 8890956

  • 61. Cell proliferation and prevalence of ras gene mutations in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors.
    Waldmann V, Suchy B, Rabes HM.
    Res Exp Med (Berl); 1993; 193(3):143-51. PubMed ID: 8356338
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
    McKenzie KE, Armstrong BA, Chen Y, Nagarajan M, Aldaz CM, Sukumar S.
    Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
    [Abstract] [Full Text] [Related]

  • 66. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
    Ronai Z, Lau YY, Cohen LA.
    Mol Carcinog; 1991 Oct; 4(2):120-8. PubMed ID: 2043252
    [Abstract] [Full Text] [Related]

  • 67. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands.
    Sakai H, Ogawa K.
    Int J Cancer; 1991 Aug 19; 49(1):140-4. PubMed ID: 1874567
    [Abstract] [Full Text] [Related]

  • 68. Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic rats.
    Hamaguchi T, Matsuoka Y, Kawaguchi H, Fukamachi K, Takasuka N, Ueda S, Shimizu K, Ohki M, Kusunoki M, Sakakura T, Yoshida H, Tsuda H.
    Breast Cancer Res Treat; 2004 Jan 19; 83(1):43-56. PubMed ID: 14997054
    [Abstract] [Full Text] [Related]

  • 69. Determination of the number of events required for mammary carcinogenesis in the Sprague-Dawley female rat.
    Isaacs JT.
    Cancer Res; 1985 Oct 19; 45(10):4827-32. PubMed ID: 3928142
    [Abstract] [Full Text] [Related]

  • 70. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
    Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M.
    Nature; 1985 Oct 19; 315(6018):382-5. PubMed ID: 3923365
    [Abstract] [Full Text] [Related]

  • 71. Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors.
    Roberts-Thomson SJ, Snyderwine EG.
    Mol Carcinog; 1997 Dec 19; 20(4):348-54. PubMed ID: 9433479
    [Abstract] [Full Text] [Related]

  • 72. Frequent c-Ha-ras gene mutations in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Hokaiwado N, Asamoto M, Cho YM, Imaida K, Shirai T.
    Cancer Lett; 2001 Feb 26; 163(2):187-90. PubMed ID: 11165753
    [Abstract] [Full Text] [Related]

  • 73. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat.
    Isaacs JT.
    Cancer Res; 1986 Aug 26; 46(8):3958-63. PubMed ID: 3089584
    [Abstract] [Full Text] [Related]

  • 74. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
    Wang BC, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN.
    Cancer Res; 1991 May 15; 51(10):2642-8. PubMed ID: 2021942
    [Abstract] [Full Text] [Related]

  • 75. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ushijima T, Kakiuchi H, Makino H, Hasegawa R, Ishizaka Y, Hirai H, Yazaki Y, Ito N, Sugimura T, Nagao M.
    Mol Carcinog; 1994 May 15; 10(1):38-44. PubMed ID: 8185828
    [Abstract] [Full Text] [Related]

  • 76. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
    Park CB, Fukamachi K, Takasuka N, Han BS, Kim CK, Hamaguchi T, Fujita K, Ueda S, Tsuda H.
    Cancer Sci; 2004 Mar 15; 95(3):205-10. PubMed ID: 15016318
    [Abstract] [Full Text] [Related]

  • 77. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
    Vuorio T, Wärri A, Sandberg M, Alitalo K, Vuorio E.
    Int J Cancer; 1988 Nov 15; 42(5):774-9. PubMed ID: 2972630
    [Abstract] [Full Text] [Related]

  • 78. Comparison of O6-methylguanine-DNA methyltransferase mRNA levels in Ha-ras mutated and non-mutated rat mammary tumors induced by N-methyl-N-nitrosourea.
    Inui H, Watatani M, Yasutomi M, Nishisho I.
    Carcinogenesis; 1994 Mar 15; 15(3):459-63. PubMed ID: 8118929
    [Abstract] [Full Text] [Related]

  • 79. DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7, 12-dimethylbenz[a]anthracene.
    Manjanatha MG, Shelton SD, Culp SJ, Blankenship LR, Casciano DA.
    Carcinogenesis; 2000 Feb 15; 21(2):265-73. PubMed ID: 10657967
    [Abstract] [Full Text] [Related]

  • 80. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats.
    Cha RS, Guerra L, Thilly WG, Zarbl H.
    Carcinogenesis; 1996 Nov 15; 17(11):2519-24. PubMed ID: 8968072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.